对于的神经调节
Nathan J Pertsch1, Kazuki Sakakura, Sepehr Sani1
1Department of Neurosurgery, Rush University Medical Center, Chicago, Illinois, USA.
The Neurodiagnostic journal
|July 3, 2025
概括
手术使用神经生理学来绘制发作的地图. 对于困难的病例,神经调节可以通过诸如迷走神经刺激,深度大脑刺激和响应性神经刺激等设备来缓解发作.
科学领域:
- 神经学 神经学
- 神经外科 神经外科
- 生物医学工程 生物医学工程
背景情况:
- 手术的目的是通过各种程序来减少或消除发作.
- 术内神经生理学有助于绘制焦点和关键大脑区域的地图.
- 对于具有扩散性,多焦点性或雄辩性发作的耐药性来说,切除是不可行的.
研究的目的:
- 探索神经调节作为药物耐药性的息治疗方法.
- 审查FDA批准的神经调节器件用于管理.
- 讨论神经调节疗法的疗效和益处.
主要方法:
- 对的神经调节技术的审查.
- 美国食品和药物管理局批准的设备描述:迷走神经刺激,深度大脑刺激 (丘脑前核) 和响应性神经刺激.
- 对发作减少率和时间效益的分析.
主要成果:
- 神经调节技术是缓解的,与治疗性切除手术不同.
- 有三种FDA批准的神经调节方式用于治疗.
- 患者经历了显著的发作减少 (>50%),随着时间的推移,益处会增加.
结论:
- 神经调节提供了一个有价值的替代药物耐药性,当切除是不可能的.
- 迷你神经刺激,深度大脑刺激和响应性神经刺激提供了缓解性控制.
- 这些疗法证明了急性和慢性益处,随着时间的推移改善了的负担.
相关概念视频
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
456
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
456
Epilepsy and Seizures: Overview
291
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
291
Antiepileptic Drugs: GABAergic Pathway Potentiators
665
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
665
Antiepileptic Drugs: Glutamate Antagonists
523
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
523
Antiepileptic Drugs: Potassium Channel Activators
283
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
283
Antiepileptic Drugs: Sodium Channel Blockers
911
Antiepileptic drugs are specialized medications that prevent seizures in individuals diagnosed with epilepsy. These drugs primarily function by blocking the movement of sodium ions through channels in the neuronal membrane, inhibiting the repetitive firing of action potentials often associated with seizures.
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
911


